POS1155 IMPACT OF HYDROXYCHLOROQUINE ON INTERFERON PATHWAY EXPRESSION OF SLE PHENOTYPIC SUBSETS IN THE ABSENCE OF BACKGROUND MEDICATIONS Article Swipe

PDF

C. Mowery , Miles Smith , Kevin L. Thomas , Susan Macwana , Wilco de Jager , Stan Kamp , B. Parrish , Cristina Arriens , Teresa Aberle , Joan T. Merrill , Joel M. Guthridge , J. A. James ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1136/annrheumdis-2023-eular.4082

Related Topics

Infectious Diseases (Medical Specialty)

Concepts

Hydroxychloroquine Medicine Interferon Immune system Phenotype Immunology Population Immune dysregulation Internal medicine Gene Biology Genetics Environmental health Disease Coronavirus disease 2019 (COVID-19) Infectious disease (medical specialty)

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1136/annrheumdis-2023-eular.4082
PDF: https://ard.bmj.com/content/annrheumdis/82/Suppl_1/909.1.full.pdf
OA Status: bronze
Cited By: 1
Related Works: 10
OpenAlex ID: https://openalex.org/W4379793030

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4379793030

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1136/annrheumdis-2023-eular.4082

Digital Object Identifier
Title: POS1155 IMPACT OF HYDROXYCHLOROQUINE ON INTERFERON PATHWAY EXPRESSION OF SLE PHENOTYPIC SUBSETS IN THE ABSENCE OF BACKGROUND MEDICATIONS

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-06-01

Full publication date if available
Authors: C. Mowery, Miles Smith, Kevin L. Thomas, Susan Macwana, Wilco de Jager, Stan Kamp, B. Parrish, Cristina Arriens, Teresa Aberle, Joan T. Merrill, Joel M. Guthridge, J. A. James

List of authors in order
Landing page: https://doi.org/10.1136/annrheumdis-2023-eular.4082

Publisher landing page
PDF URL: https://ard.bmj.com/content/annrheumdis/82/Suppl_1/909.1.full.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://ard.bmj.com/content/annrheumdis/82/Suppl_1/909.1.full.pdf

Direct OA link when available
Concepts: Hydroxychloroquine, Medicine, Interferon, Immune system, Phenotype, Immunology, Population, Immune dysregulation, Internal medicine, Gene, Biology, Genetics, Environmental health, Disease, Coronavirus disease 2019 (COVID-19), Infectious disease (medical specialty)

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2024: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4379793030
doi	https://doi.org/10.1136/annrheumdis-2023-eular.4082
ids.doi	https://doi.org/10.1136/annrheumdis-2023-eular.4082
ids.openalex	https://openalex.org/W4379793030
fwci	0.41037444
type	article
title	POS1155 IMPACT OF HYDROXYCHLOROQUINE ON INTERFERON PATHWAY EXPRESSION OF SLE PHENOTYPIC SUBSETS IN THE ABSENCE OF BACKGROUND MEDICATIONS
biblio.issue
biblio.volume	82
biblio.last_page	909
biblio.first_page	909
topics[0].id	https://openalex.org/T10308
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9969000220298767
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2745
topics[0].subfield.display_name	Rheumatology
topics[0].display_name	Systemic Lupus Erythematosus Research
topics[1].id	https://openalex.org/T11157
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9926999807357788
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2716
topics[1].subfield.display_name	Genetics
topics[1].display_name	Chronic Lymphocytic Leukemia Research
topics[2].id	https://openalex.org/T12817
topics[2].field.id	https://openalex.org/fields/30
topics[2].field.display_name	Pharmacology, Toxicology and Pharmaceutics
topics[2].score	0.9753999710083008
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/3004
topics[2].subfield.display_name	Pharmacology
topics[2].display_name	Pharmacological Effects of Natural Compounds
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2779123688
concepts[0].level	5
concepts[0].score	0.9454900622367859
concepts[0].wikidata	https://www.wikidata.org/wiki/Q421094
concepts[0].display_name	Hydroxychloroquine
concepts[1].id	https://openalex.org/C71924100
concepts[1].level	0
concepts[1].score	0.7967824339866638
concepts[1].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[1].display_name	Medicine
concepts[2].id	https://openalex.org/C2776178377
concepts[2].level	2
concepts[2].score	0.6490142345428467
concepts[2].wikidata	https://www.wikidata.org/wiki/Q188269
concepts[2].display_name	Interferon
concepts[3].id	https://openalex.org/C8891405
concepts[3].level	2
concepts[3].score	0.6276017427444458
concepts[3].wikidata	https://www.wikidata.org/wiki/Q1059
concepts[3].display_name	Immune system
concepts[4].id	https://openalex.org/C127716648
concepts[4].level	3
concepts[4].score	0.5977158546447754
concepts[4].wikidata	https://www.wikidata.org/wiki/Q104053
concepts[4].display_name	Phenotype
concepts[5].id	https://openalex.org/C203014093
concepts[5].level	1
concepts[5].score	0.5785356163978577
concepts[5].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[5].display_name	Immunology
concepts[6].id	https://openalex.org/C2908647359
concepts[6].level	2
concepts[6].score	0.4632514715194702
concepts[6].wikidata	https://www.wikidata.org/wiki/Q2625603
concepts[6].display_name	Population
concepts[7].id	https://openalex.org/C2780194698
concepts[7].level	3
concepts[7].score	0.4167824983596802
concepts[7].wikidata	https://www.wikidata.org/wiki/Q6005429
concepts[7].display_name	Immune dysregulation
concepts[8].id	https://openalex.org/C126322002
concepts[8].level	1
concepts[8].score	0.37757429480552673
concepts[8].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[8].display_name	Internal medicine
concepts[9].id	https://openalex.org/C104317684
concepts[9].level	2
concepts[9].score	0.21298667788505554
concepts[9].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[9].display_name	Gene
concepts[10].id	https://openalex.org/C86803240
concepts[10].level	0
concepts[10].score	0.11122384667396545
concepts[10].wikidata	https://www.wikidata.org/wiki/Q420
concepts[10].display_name	Biology
concepts[11].id	https://openalex.org/C54355233
concepts[11].level	1
concepts[11].score	0.06976309418678284
concepts[11].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[11].display_name	Genetics
concepts[12].id	https://openalex.org/C99454951
concepts[12].level	1
concepts[12].score	0.0
concepts[12].wikidata	https://www.wikidata.org/wiki/Q932068
concepts[12].display_name	Environmental health
concepts[13].id	https://openalex.org/C2779134260
concepts[13].level	2
concepts[13].score	0.0
concepts[13].wikidata	https://www.wikidata.org/wiki/Q12136
concepts[13].display_name	Disease
concepts[14].id	https://openalex.org/C3008058167
concepts[14].level	4
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q84263196
concepts[14].display_name	Coronavirus disease 2019 (COVID-19)
concepts[15].id	https://openalex.org/C524204448
concepts[15].level	3
concepts[15].score	0.0
concepts[15].wikidata	https://www.wikidata.org/wiki/Q788926
concepts[15].display_name	Infectious disease (medical specialty)
keywords[0].id	https://openalex.org/keywords/hydroxychloroquine
keywords[0].score	0.9454900622367859
keywords[0].display_name	Hydroxychloroquine
keywords[1].id	https://openalex.org/keywords/medicine
keywords[1].score	0.7967824339866638
keywords[1].display_name	Medicine
keywords[2].id	https://openalex.org/keywords/interferon
keywords[2].score	0.6490142345428467
keywords[2].display_name	Interferon
keywords[3].id	https://openalex.org/keywords/immune-system
keywords[3].score	0.6276017427444458
keywords[3].display_name	Immune system
keywords[4].id	https://openalex.org/keywords/phenotype
keywords[4].score	0.5977158546447754
keywords[4].display_name	Phenotype
keywords[5].id	https://openalex.org/keywords/immunology
keywords[5].score	0.5785356163978577
keywords[5].display_name	Immunology
keywords[6].id	https://openalex.org/keywords/population
keywords[6].score	0.4632514715194702
keywords[6].display_name	Population
keywords[7].id	https://openalex.org/keywords/immune-dysregulation
keywords[7].score	0.4167824983596802
keywords[7].display_name	Immune dysregulation
keywords[8].id	https://openalex.org/keywords/internal-medicine
keywords[8].score	0.37757429480552673
keywords[8].display_name	Internal medicine
keywords[9].id	https://openalex.org/keywords/gene
keywords[9].score	0.21298667788505554
keywords[9].display_name	Gene
keywords[10].id	https://openalex.org/keywords/biology
keywords[10].score	0.11122384667396545
keywords[10].display_name	Biology
keywords[11].id	https://openalex.org/keywords/genetics
keywords[11].score	0.06976309418678284
keywords[11].display_name	Genetics
language	en
locations[0].id	doi:10.1136/annrheumdis-2023-eular.4082
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S25650217
locations[0].source.issn	0003-4967, 1468-2060
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0003-4967
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of the Rheumatic Diseases
locations[0].source.host_organization	https://openalex.org/P4310319945
locations[0].source.host_organization_name	BMJ
locations[0].source.host_organization_lineage	https://openalex.org/P4310319945
locations[0].source.host_organization_lineage_names	BMJ
locations[0].license
locations[0].pdf_url	https://ard.bmj.com/content/annrheumdis/82/Suppl_1/909.1.full.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of the Rheumatic Diseases
locations[0].landing_page_url	https://doi.org/10.1136/annrheumdis-2023-eular.4082
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5039490220
authorships[0].author.orcid
authorships[0].author.display_name	C. Mowery
authorships[0].countries	SE
authorships[0].affiliations[0].institution_ids	https://openalex.org/I26437253
authorships[0].affiliations[0].raw_affiliation_string	Örebro University, Department of Rheumatology, Faculty of Medicine and Health, Örebro, Sweden;
authorships[0].affiliations[1].institution_ids	https://openalex.org/I1335113835, https://openalex.org/I28166907
authorships[0].affiliations[1].raw_affiliation_string	Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden;
authorships[0].institutions[0].id	https://openalex.org/I28166907
authorships[0].institutions[0].ror	https://ror.org/056d84691
authorships[0].institutions[0].type	education
authorships[0].institutions[0].lineage	https://openalex.org/I28166907
authorships[0].institutions[0].country_code	SE
authorships[0].institutions[0].display_name	Karolinska Institutet
authorships[0].institutions[1].id	https://openalex.org/I1335113835
authorships[0].institutions[1].ror	https://ror.org/00m8d6786
authorships[0].institutions[1].type	healthcare
authorships[0].institutions[1].lineage	https://openalex.org/I1335113835
authorships[0].institutions[1].country_code	SE
authorships[0].institutions[1].display_name	Karolinska University Hospital
authorships[0].institutions[2].id	https://openalex.org/I26437253
authorships[0].institutions[2].ror	https://ror.org/05kytsw45
authorships[0].institutions[2].type	education
authorships[0].institutions[2].lineage	https://openalex.org/I26437253
authorships[0].institutions[2].country_code	SE
authorships[0].institutions[2].display_name	Örebro University
authorships[0].author_position	first
authorships[0].raw_author_name	C. Mowery
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden;, Örebro University, Department of Rheumatology, Faculty of Medicine and Health, Örebro, Sweden;
authorships[1].author.id	https://openalex.org/A5057418379
authorships[1].author.orcid	https://orcid.org/0000-0003-0651-809X
authorships[1].author.display_name	Miles Smith
authorships[1].countries	US
authorships[1].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[1].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[1].institutions[0].id	https://openalex.org/I30558944
authorships[1].institutions[0].ror	https://ror.org/035z6xf33
authorships[1].institutions[0].type	nonprofit
authorships[1].institutions[0].lineage	https://openalex.org/I30558944
authorships[1].institutions[0].country_code	US
authorships[1].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[1].author_position	middle
authorships[1].raw_author_name	M. Smith
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[2].author.id	https://openalex.org/A5023508111
authorships[2].author.orcid	https://orcid.org/0000-0002-0040-5396
authorships[2].author.display_name	Kevin L. Thomas
authorships[2].countries	US
authorships[2].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[2].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[2].institutions[0].id	https://openalex.org/I30558944
authorships[2].institutions[0].ror	https://ror.org/035z6xf33
authorships[2].institutions[0].type	nonprofit
authorships[2].institutions[0].lineage	https://openalex.org/I30558944
authorships[2].institutions[0].country_code	US
authorships[2].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[2].author_position	middle
authorships[2].raw_author_name	K. Thomas
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[3].author.id	https://openalex.org/A5046774559
authorships[3].author.orcid
authorships[3].author.display_name	Susan Macwana
authorships[3].countries	US
authorships[3].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[3].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[3].institutions[0].id	https://openalex.org/I30558944
authorships[3].institutions[0].ror	https://ror.org/035z6xf33
authorships[3].institutions[0].type	nonprofit
authorships[3].institutions[0].lineage	https://openalex.org/I30558944
authorships[3].institutions[0].country_code	US
authorships[3].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[3].author_position	middle
authorships[3].raw_author_name	S. Macwana
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[4].author.id	https://openalex.org/A5055575694
authorships[4].author.orcid	https://orcid.org/0000-0002-0014-0682
authorships[4].author.display_name	Wilco de Jager
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[4].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[4].institutions[0].id	https://openalex.org/I30558944
authorships[4].institutions[0].ror	https://ror.org/035z6xf33
authorships[4].institutions[0].type	nonprofit
authorships[4].institutions[0].lineage	https://openalex.org/I30558944
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[4].author_position	middle
authorships[4].raw_author_name	W. Dejager
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[5].author.id	https://openalex.org/A5024269575
authorships[5].author.orcid
authorships[5].author.display_name	Stan Kamp
authorships[5].countries	US
authorships[5].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[5].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[5].institutions[0].id	https://openalex.org/I30558944
authorships[5].institutions[0].ror	https://ror.org/035z6xf33
authorships[5].institutions[0].type	nonprofit
authorships[5].institutions[0].lineage	https://openalex.org/I30558944
authorships[5].institutions[0].country_code	US
authorships[5].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[5].author_position	middle
authorships[5].raw_author_name	S. Kamp
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[6].author.id	https://openalex.org/A5050355963
authorships[6].author.orcid
authorships[6].author.display_name	B. Parrish
authorships[6].countries	US
authorships[6].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[6].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[6].institutions[0].id	https://openalex.org/I30558944
authorships[6].institutions[0].ror	https://ror.org/035z6xf33
authorships[6].institutions[0].type	nonprofit
authorships[6].institutions[0].lineage	https://openalex.org/I30558944
authorships[6].institutions[0].country_code	US
authorships[6].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[6].author_position	middle
authorships[6].raw_author_name	B. Parrish
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[7].author.id	https://openalex.org/A5031271622
authorships[7].author.orcid	https://orcid.org/0000-0002-9546-1664
authorships[7].author.display_name	Cristina Arriens
authorships[7].countries	US
authorships[7].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[7].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[7].institutions[0].id	https://openalex.org/I30558944
authorships[7].institutions[0].ror	https://ror.org/035z6xf33
authorships[7].institutions[0].type	nonprofit
authorships[7].institutions[0].lineage	https://openalex.org/I30558944
authorships[7].institutions[0].country_code	US
authorships[7].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[7].author_position	middle
authorships[7].raw_author_name	C. Arriens
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[8].author.id	https://openalex.org/A5065167560
authorships[8].author.orcid
authorships[8].author.display_name	Teresa Aberle
authorships[8].countries	US
authorships[8].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[8].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[8].institutions[0].id	https://openalex.org/I30558944
authorships[8].institutions[0].ror	https://ror.org/035z6xf33
authorships[8].institutions[0].type	nonprofit
authorships[8].institutions[0].lineage	https://openalex.org/I30558944
authorships[8].institutions[0].country_code	US
authorships[8].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[8].author_position	middle
authorships[8].raw_author_name	T. Aberle
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[9].author.id	https://openalex.org/A5052053321
authorships[9].author.orcid	https://orcid.org/0000-0002-4514-2382
authorships[9].author.display_name	Joan T. Merrill
authorships[9].countries	US
authorships[9].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[9].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[9].institutions[0].id	https://openalex.org/I30558944
authorships[9].institutions[0].ror	https://ror.org/035z6xf33
authorships[9].institutions[0].type	nonprofit
authorships[9].institutions[0].lineage	https://openalex.org/I30558944
authorships[9].institutions[0].country_code	US
authorships[9].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[9].author_position	middle
authorships[9].raw_author_name	J. T. Merrill
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[10].author.id	https://openalex.org/A5032779152
authorships[10].author.orcid	https://orcid.org/0000-0002-9308-237X
authorships[10].author.display_name	Joel M. Guthridge
authorships[10].countries	US
authorships[10].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[10].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[10].institutions[0].id	https://openalex.org/I30558944
authorships[10].institutions[0].ror	https://ror.org/035z6xf33
authorships[10].institutions[0].type	nonprofit
authorships[10].institutions[0].lineage	https://openalex.org/I30558944
authorships[10].institutions[0].country_code	US
authorships[10].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[10].author_position	middle
authorships[10].raw_author_name	J. Guthridge
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[11].author.id	https://openalex.org/A5113611091
authorships[11].author.orcid
authorships[11].author.display_name	J. A. James
authorships[11].countries	US
authorships[11].affiliations[0].institution_ids	https://openalex.org/I30558944
authorships[11].affiliations[0].raw_affiliation_string	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
authorships[11].institutions[0].id	https://openalex.org/I30558944
authorships[11].institutions[0].ror	https://ror.org/035z6xf33
authorships[11].institutions[0].type	nonprofit
authorships[11].institutions[0].lineage	https://openalex.org/I30558944
authorships[11].institutions[0].country_code	US
authorships[11].institutions[0].display_name	Oklahoma Medical Research Foundation
authorships[11].author_position	last
authorships[11].raw_author_name	J. A. James
authorships[11].is_corresponding	False
authorships[11].raw_affiliation_strings	Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, United States of America
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://ard.bmj.com/content/annrheumdis/82/Suppl_1/909.1.full.pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	POS1155 IMPACT OF HYDROXYCHLOROQUINE ON INTERFERON PATHWAY EXPRESSION OF SLE PHENOTYPIC SUBSETS IN THE ABSENCE OF BACKGROUND MEDICATIONS
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10308
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9969000220298767
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2745
primary_topic.subfield.display_name	Rheumatology
primary_topic.display_name	Systemic Lupus Erythematosus Research
related_works	https://openalex.org/W3110506613, https://openalex.org/W3027791452, https://openalex.org/W3149354770, https://openalex.org/W2520571625, https://openalex.org/W3124402827, https://openalex.org/W2162982134, https://openalex.org/W2789089580, https://openalex.org/W2068981458, https://openalex.org/W2035553775, https://openalex.org/W65415747
cited_by_count	1
counts_by_year[0].year	2024
counts_by_year[0].cited_by_count	1
locations_count	1
best_oa_location.id	doi:10.1136/annrheumdis-2023-eular.4082
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S25650217
best_oa_location.source.issn	0003-4967, 1468-2060
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0003-4967
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of the Rheumatic Diseases
best_oa_location.source.host_organization	https://openalex.org/P4310319945
best_oa_location.source.host_organization_name	BMJ
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310319945
best_oa_location.source.host_organization_lineage_names	BMJ
best_oa_location.license
best_oa_location.pdf_url	https://ard.bmj.com/content/annrheumdis/82/Suppl_1/909.1.full.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of the Rheumatic Diseases
best_oa_location.landing_page_url	https://doi.org/10.1136/annrheumdis-2023-eular.4082
primary_location.id	doi:10.1136/annrheumdis-2023-eular.4082
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S25650217
primary_location.source.issn	0003-4967, 1468-2060
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0003-4967
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of the Rheumatic Diseases
primary_location.source.host_organization	https://openalex.org/P4310319945
primary_location.source.host_organization_name	BMJ
primary_location.source.host_organization_lineage	https://openalex.org/P4310319945
primary_location.source.host_organization_lineage_names	BMJ
primary_location.license
primary_location.pdf_url	https://ard.bmj.com/content/annrheumdis/82/Suppl_1/909.1.full.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of the Rheumatic Diseases
primary_location.landing_page_url	https://doi.org/10.1136/annrheumdis-2023-eular.4082
publication_date	2023-06-01
publication_year	2023
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year.max	94
cited_by_percentile_year.min	90
countries_distinct_count	2
institutions_distinct_count	12
sustainable_development_goals[0].id	https://metadata.un.org/sdg/15
sustainable_development_goals[0].score	0.5899999737739563
sustainable_development_goals[0].display_name	Life in Land
citation_normalized_percentile.value	0.59546492
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False